Suzhou Highfine Biotech Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 388.79 million compared to CNY 447.46 million a year ago. Revenue was CNY 388.79 million compared to CNY 447.46 million a year ago.

Net income was CNY 98.97 million compared to CNY 129.37 million a year ago. Basic earnings per share from continuing operations was CNY 1.07 compared to CNY 1.6 a year ago. Diluted earnings per share from continuing operations was CNY 1.07 compared to CNY 1.6 a year ago.